NANOVIEW BIOSCIENCES, INC.

Boston, MA · Founded 2015 · CIK 0001754605 · Medtech · Acquired

Diagnostic imaging platform for visualizing and quantifying PD-L1 expression and tumor-infiltrating immune cells to predict immunotherapy response

Grants
$1.7M
4 awards
Sector median: 1
Raised
$18M
3 Form D · Mar 2022
55 months since last filing
Contracts
$449K
4 awards · Health and Human S
#392 of 4531 in medtech
Patents
7
2 granted · 5 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · A Scalable Blood-based Pancreatic Cancer Test for High-Risk Screening$227,001
Federal grantNational Science Foundation · Phase I · SBIR Phase I: High-Throughput Nanoparticle Characterization for Life Sciences Applications$225,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: High-Throughput and Scalable Nanoparticle Characterization for Life Sciences Applications$934,244
Private capital raisedForm D · SEC$9,000,000
Federal contractDepartment of Health and Human Services · Laboratory Testing$19,300
Private capital raisedForm D · SEC$6,000,000
Federal grantDepartment of Health and Human Services · Phase I · Single Vesicle Phenotyping of Circulating Exosomes Carrying Immunomodulatory Markers for Therapy Selection and Monitoring.$351,922
Federal contractDepartment of Health and Human Services · Nanoview Biosciences Exoview R100$140,460
Federal contractDepartment of Health and Human Services · Exoview R100 Automated Imager$122,743
Private capital raisedForm D · SEC$2,500,000
Federal contractDepartment of Health and Human Services · Nichd - Exoview R200 Instrument$166,762
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
389DIAGNOSTIC BIOCHIPS, INC$456K$1.3M
390Quel Imaging LLC$455K—
391Magnolia Medical Technologies, Inc.$452K$87M
392NANOVIEW BIOSCIENCES, INC.$449K$18M
393BENTEN TECHNOLOGIES, INC.$446K—
394HESPEROS, INC$434K—
395ZMK Medical Technologies, Inc.$422K—

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 12 related persons
  • Parker CassidyDirector
  • PARKER CASSIDYDirector
  • George DaaboulDirector · Executive Officer
  • GEORGE DAABOULDirector
  • David FreedmanExecutive Officer
  • DAVID FREEDMANExecutive Officer
  • Andrea JacksonDirector
  • ANDREA JACKSONDirector
  • Ian RatcliffeDirector
  • Michael RubinDirector
  • Gerald WilliamsonDirector · Executive Officer
  • GERALD WILLIAMSONDirector · Executive Officer

Patents

USPTO · 2 granted of 7
  • Detection Of Exosomes Having Surface Markersgranted
  • Systems And Methods For Imaging Microwell Plate Samplesgranted
  • Methods And Systems For Enhanced Interferometric Detection And Characterization Of Single Particles Via Three-dimensional Image Registrationapplication
  • Compositions, Systems, And Methods For Enhanced Label-free And Fluorescence - Based Detection Of Nanoparticlesapplication
  • Systems And Methods For Vesicle Cargo Labeling And Detectionapplication
  • Systems And Methods For Imaging Microwell Plate Samplesapplication
  • Systems And Methods For Vesicle Cargo Labeling And Detectionapplication

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.